Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
Phillip Pymm(The University of Melbourne), Wai‐Hong Tham(The University of Melbourne), R. J. Pickering(Baker Heart and Diabetes Institute), Melanie H. Dietrich(The University of Melbourne), Ebene R. Haycroft(The University of Melbourne), Marcel Doerflinger(The University of Melbourne), Hariprasad Venugopal(Monash University), Matthew T. O’Neill(Walter and Eliza Hall Institute of Medical Research), Cody C. Allison(The University of Melbourne), Nicholas A. Gherardin(Peter Doherty Institute), Nichollas E. Scott(The University of Melbourne), Li Lynn Tan(Walter and Eliza Hall Institute of Medical Research), Amy Adair(Walter and Eliza Hall Institute of Medical Research), Alisa Glukhova(The University of Melbourne), Li‐Jin Chan(The University of Melbourne), Damian F. J. Purcell(The University of Melbourne), Stephen J. Kent(The University of Melbourne), Marc Pellegrini(The University of Melbourne), Damien R. Drew(Walter and Eliza Hall Institute of Medical Research), Dale I. Godfrey(Peter Doherty Institute), Kanta Subbarao(Peter Doherty Institute), Francesca L. Mordant(The University of Melbourne), James P. Cooney(The University of Melbourne), Amy W. Chung(The University of Melbourne), Ester López(The University of Melbourne), Deborah Cromer(UNSW Sydney), Adam K. Wheatley(The University of Melbourne), Michael A. Dengler(Medical University of Graz), Miles P. Davenport(UNSW Sydney)
Cited by 165
Related Papers
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
|The EMBO Journal|2020|499
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
|Nature Medicine|2020|490